DUBLIN--(BUSINESS WIRE)--The "High-intensity Focused Ultrasound (HIFU) Therapy Market by Application (Prostate Cancer, Uterine Fibroids, Neurological Disorders, Aesthetics, and Others) - Global Opportunity Analysis and Industry Forecast, 2018-2025" report has been added to ResearchAndMarkets.com's offering.
The global HIFU therapy market was valued at $81,000 thousand in 2017, and is estimated to reach at $398,724 thousand by 2025, registering a CAGR of 21.8% from 2018 to 2025.
Upsurge in geriatric population, surge in prevalence of chronic disease such as cancer, and favorable regulatory scenario towards HIFU devices are the key factors that augment the growth of the global HIFU therapy market. Furthermore, rise in awareness for early disease diagnosis is expected to boost the market growth.
However, lack of skilled professionals and limitations associated with HIFU therapy are some of the factors that impede the market growth. Conversely, high potential of emerging economies and increase in demand of HIFU devices are expected to provide new opportunities for the market players in future.
Key Players Profiled
- Chongqing Haifu Medical Technology Co. Ltd.
- EDAP TMS S.A.
- SonaCare Medical, LLC
- ILJIN Holdings Co. Ltd.
- Image Guided Therapy S.A.
- Insightec Ltd.
- Theraclion SA
-
Merz Pharmaceuticals GmbH
- Profound Medical Corp.
- Shanghai A&S Technology Development Co. Ltd.
Key Topics Covered
Chapter 1: Introduction
Chapter 2: Executive Summary
Chapter 3: Market Overview
Chapter 4: High-Intensity Focused Ultrasound (HIFU) Therapy Market, by Application
Chapter 5: High-Intensity Focused Ultrasound (HIFU) Market, by Region
Chapter 6: Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/csrv45/global?w=4
